The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K.
Radar 89 (high attention) · dilution pressure high · listing risk low · governance risk low · runway 8.4 mo · strongest signal: Insider selling before raise (Aug 10, 2026)
What would confirm: 424B5/8-K announcing an offering, ATM sales disclosed in next 10-Q, or Form 4 sales by insiders ahead of it.
What would prove it wrong: Non-dilutive cash event (asset sale, grant, milestone payment), OCF turning positive, or shelf withdrawn (RW).
Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.
Independent filings stitched into a thesis, each with what would confirm and what would prove it wrong.
The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K. Cash need (runway 6–12 months) coexists with live selling machinery (atm program, shelf effective, shelf filed, offering (424b)). Base case is a discounted raise; the question is when, not if.
No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.
Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 47 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.
Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.
| Date | Signal | Evidence | Score |
|---|---|---|---|
| Aug 14, 2026 | ▼ Shelf filed | S-3ASR filed 2026-08-14 filing | 32 |
| Aug 14, 2026 | ▼ Going-concern language | “going concern periodic” language in 10-Q (10-Q) filed 2026-08-14 filing | 25 |
| Aug 12, 2026 | · Form 4 burst | 5 Form 4 filings in 30 days filing | 15 |
| Aug 11, 2026 | · 13D amendment | Schedule 13D/A filed 2026-08-11 filing | 24 |
| Aug 10, 2026 | ▼ Insider selling before raise | 4 insider open-market sale(s) in the 45 days before financing filing on 2026-08-10: Patel Sushil 39,[email protected] 2026-08-10; Hill Emily Luisa 11,[email protected] 2026-08-10; Xynos Konstantinos 11,[email protected] 2026-08-10 filing | 67 |
| Aug 10, 2026 | ▼ Offering (424B) | 424B5 prospectus supplement 2026-08-10; 0 prior 424B filings in 12m filing | 50 |
| Aug 10, 2026 | ▼ Insider selling cluster | 4 open-market sales by 4 insider(s) (~$906,188) in 30d filing | 44 |
| Aug 10, 2026 | ▼ ATM program | “atm” language in 424B5 (424B5) filed 2026-08-10 filing | 38 |
| Aug 10, 2026 | ▼ Delisting language | “delisting notice” language in 8-K (EX-1.1) filed 2026-08-10 filing | 32 |
| Jul 29, 2026 | ▼ Shelf effective | EFFECT notice 2026-07-29 filing | 21 |
| Jul 24, 2026 | ▼ ATM program | “atm” language in S-3/A (S-3/A) filed 2026-07-24 filing | 38 |
| Jul 24, 2026 | ▼ Shelf filed | S-3/A filed 2026-07-24 filing | 35 |
| Jun 30, 2026 | ▼ Runway 6–12 months | ~8.4 months runway: liquidity $195,328,000 (cash $185,359,000 + investments $9,969,000) as of 2026-06-30, burn $280,344,000/yr (latest fiscal-year operating cash flow (quarter too short to annualize) [companyfacts]) filing | 25 |
VIVS VivoSim Labs, INC. · HCWB HCW Biologics Inc. · CYCU Cycurion, Inc. · BIAF bioAffinity Technologies, In · XHLD TEN Holdings, Inc. · VSEE VSEE HEALTH, INC. · screener →